Table 1 Demographic data of the three groups.

From: Dexamethasone with aggressive warming facilitates pain reduction, reduced blood loss, and quicker recovery after total hip arthroplasty

 

Group A

Group B

Group C

P value

N

50

50

50

Age (y)

64.02 ± 5.82

64.22 ± 5.46

63.94 ± 4.03

0.96

Gender (M/F)

21/29

14/36

20/30

0.29

Height (m)

1.62 ± 0.08

1.62 ± 0.07

1.63 ± 0.06

0.75

Weight (kg)

64.39 ± 8.30

64.61 ± 6.48

64.46 ± 5.12

0.98

BMI (kg/m2)

24.63 ± 2.77

24.73 ± 3.08

24.43 ± 2.30

0.37

Hypertension (Y/N)

11/39

10/40

13/37

0.77

Diabetes (Y/N)

2/48

3/37

2/48

0.86

Etiology (ONFH/OA/DDH)

27/14/9

24/16/10

29/14/7

0.88

Preoperative CRP

7.86 ± 2.67

7.60 ± 2.19

7.92 ± 2.19

0.78

Preoperative IL-6

2.33 ± 1.38

2.48 ± 1.54

2.49 ± 1.34

0.81

Preoperative rest VAS

5.44 ± 0.86

5.34 ± 1.08

5.40 ± 0.90

0.87

Preoperative motive VAS

7.98 ± 0.87

8.04 ± 0.88

7.88 ± 0.80

0.64

Preoperative ICFS score

61.76 ± 5.86

62.58 ± 4.49

63.34 ± 4.46

0.29

Preoperative ROM

90.48 ± 4.10

91.20 ± 3.85

91.24 ± 3.73

0.55

Preoperative Hb

126.12 ± 8.89

126.06 ± 7.04

125.74 ± 6.78

0.97

  1. BMI Body Mass Index, ONFH osteonecrosis of the femoral head, OA osteoarthritis, DDH developmental dysplasia of the hip, CRP C-reactive protein, IL-6 interleukin-6, ICFS Identity-Consequence-Fatigue Scale, ROM range of motion, Hb hemoglobin.